Amiable, Nathalie <br/><br/>
Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts.  [electronic resource] 

 -  Bone  Jun 2009 
 - 1143-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2763 
<br/><br/><label>Standard No.: </label>10.1016/j.bone.2009.02.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Resorption--metabolism<br/>Cells, Cultured<br/>Dinoprostone--pharmacology<br/>Enzyme-Linked Immunosorbent Assay<br/>Flow Cytometry<br/>Humans<br/>Interleukin-17--pharmacology<br/>Interleukin-1beta--pharmacology<br/>Interleukin-6--pharmacology<br/>Matrix Metalloproteinase 1--metabolism<br/>Matrix Metalloproteinase 13--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Middle Aged<br/>Osteoarthritis--metabolism<br/>Osteoblasts--drug effects<br/>RANK Ligand--genetics<br/>Receptor, PAR-2--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transforming Growth Factor beta1--pharmacology<br/>Tumor Necrosis Factor-alpha--pharmacology